New drug delivery for corneal neovascularization using polyion complex micelles

Area of Science:

• Ophthalmology
• Nanotechnology
• Biomedical Engineering

Background:

• Corneal neovascularization (NV) poses a significant challenge in ophthalmology.
• Next-generation photodynamic therapy (PDT) requires targeted drug delivery systems for enhanced efficacy.
• Polyion complex (PIC) micelles represent a novel nanocarrier platform for therapeutic applications.

Purpose of the Study:

• To develop and evaluate polyion complex (PIC) micelles as a drug delivery system for photodynamic therapy (PDT) targeting corneal neovascularization (NV).
• To assess the stability, drug-loading capacity, and controlled release potential of PIC micelles encapsulating a photosensitizer.

Main Methods:

• Synthesized PIC micelles with a polyethylene glycol (PEG) shell for enhanced stability and drug delivery.
• Encapsulated the photosensitizer dendrimer porphyrin (DP) into PIC micelles, forming DP-micelles.
• Evaluated the photophysical properties, stability, and photocytotoxicity of DP-micelles.
• Assessed the in vivo accumulation and targeting of DP-micelles in corneal NV sites.

Main Results:

• PIC micelles demonstrated good stability, high drug-loading capacity, and controlled release properties.
• DP-micelles maintained the photophysical properties of dendrimer porphyrin (DP) while exhibiting increased photocytotoxicity.
• DP-micelles showed selective accumulation and incorporation into the corneal NV area.
• The developed system proved effective in targeting corneal neovascularization.

Conclusions:

• Polyion complex (PIC) micelles are a promising nanocarrier system for targeted delivery in ophthalmology.
• PDT utilizing DP-loaded PIC micelles is an effective and safe therapeutic strategy for corneal neovascularization (NV).
• This novel approach advances the treatment landscape for corneal vascular disorders.